Benjamin J. Hindson's Insider Trades & SAST Disclosures
Benjamin J. Hindson's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 7,485 Class A Common Stock done at an average price of $8.3 . Disclosure was reported to the exchange on May 22, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Benjamin J. Hindson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 8.30 per share. | 22 May 2025 | 7,485 | 448,374 (2%) | 0% | 8.3 | 62,120 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 120,535 | 455,859 (2%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 24 Feb 2025 | 4,573 | 335,324 (1%) | 0% | 11.1 | 50,603 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.69 per share. | 22 Nov 2024 | 5,807 | 339,897 (1%) | 0% | 13.7 | 79,485 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 22.53 per share. | 22 Aug 2024 | 4,351 | 345,704 (1%) | 0% | 22.5 | 98,027 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 24.30 per share. | 22 May 2024 | 4,087 | 350,055 (1%) | 0% | 24.3 | 99,329 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 71,083 | 354,142 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | J. Hindson Benjamin | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 46.34 per share. | 22 Feb 2024 | 2,613 | 283,059 (1%) | 0% | 46.3 | 121,098 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Hindson Benjamin J. | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 8,334 | 14,978 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 28 Dec 2023 | 8,334 | 285,672 (1%) | 0% | 11.5 | 95,674 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 45.78 per share. | 22 Aug 2023 | 3,449 | 280,787 (1%) | 0% | 45.8 | 157,899 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 6,970 | 23,312 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 01 Aug 2023 | 6,970 | 291,206 (1%) | 0% | 11.5 | 80,016 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 62.36 per share. | 01 Aug 2023 | 5,243 | 284,236 (1%) | 0% | 62.4 | 326,933 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 61.77 per share. | 01 Aug 2023 | 1,727 | 289,479 (1%) | 0% | 61.8 | 106,679 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 60.03 per share. | 19 Jul 2023 | 13,940 | 284,236 (1%) | 0% | 60.0 | 836,834 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 19 Jul 2023 | 12,972 | 297,208 (1%) | 0% | 5.0 | 65,379 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 12,972 | 0 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 968 | 30,282 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 19 Jul 2023 | 968 | 298,176 (1%) | 0% | 11.5 | 11,113 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 791 | 284,236 (1%) | 0% | 55.1 | 43,553 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 735 | 285,027 (1%) | 0% | 55.1 | 40,471 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 619 | 285,762 (1%) | 0% | 55.1 | 34,082 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 243 | 286,381 (1%) | 0% | 55.1 | 13,379 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 36,387 | 36,387 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 36,387 | 286,624 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 18,194 | 18,194 | - | - | Performance- based Restricted Stock Units | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 47.75 per share. | 22 Feb 2023 | 1,742 | 250,237 (1%) | 0% | 47.8 | 83,186 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 1,087 | 217,713 (1%) | 0% | 34.1 | 37,032 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 915 | 218,800 (1%) | 0% | 34.1 | 31,172 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 359 | 219,715 (1%) | 0% | 34.1 | 12,230 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 67,655 | 67,655 | - | - | Performance-based Restricted Stock Units | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 67,655 | 67,655 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 33,828 | 220,074 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 35.19 per share. | 23 Aug 2022 | 1,292 | 186,246 (0%) | 0% | 35.2 | 45,467 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 48.76 per share. | 23 May 2022 | 1,264 | 187,538 (0%) | 0% | 48.8 | 61,637 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 71,189 | 71,189 | - | - | Stock Option (Right to Buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 28,476 | 188,802 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Feb 2022 | 267,000 | 2,733,000 | - | - | Class B Common Stock | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Feb 2022 | 133,500 | 133,500 | - | - | Class B Common Stock | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Feb 2022 | 133,500 | 133,500 | - | - | Class B Common Stock | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 78.59 per share. | 22 Feb 2022 | 360 | 160,326 (0%) | 0% | 78.6 | 28,294 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.58 per share. | 03 Jan 2022 | 39,582 | 202,352 (0%) | 0% | 74.6 | 2,952,026 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 39,582 | 93,630 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 146.29 per share. | 03 Jan 2022 | 17,396 | 166,192 (0%) | 0% | 146.3 | 2,544,927 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 145.43 per share. | 03 Jan 2022 | 16,464 | 183,588 (0%) | 0% | 145.4 | 2,394,422 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 147.34 per share. | 03 Jan 2022 | 2,906 | 163,286 (0%) | 0% | 147.3 | 428,160 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 144.56 per share. | 03 Jan 2022 | 2,300 | 200,052 (0%) | 0% | 144.6 | 332,478 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 2,084 | 31,250 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 03 Jan 2022 | 2,084 | 162,770 (0%) | 0% | 11.5 | 23,924 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 148.44 per share. | 03 Jan 2022 | 2,000 | 161,286 (0%) | 0% | 148.4 | 296,871 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 149.24 per share. | 03 Jan 2022 | 600 | 160,686 (0%) | 0% | 149.2 | 89,546 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 59,968 | 0 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 28 Dec 2021 | 59,968 | 160,686 (0%) | 0% | 1.2 | 71,962 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 53,952 | 0 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. | 28 Dec 2021 | 53,952 | 100,718 (0%) | 0% | 1.1 | 57,729 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 35,232 | 33,334 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 01 Dec 2021 | 35,232 | 85,644 (0%) | 0% | 11.5 | 404,463 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 147.65 per share. | 01 Dec 2021 | 13,561 | 64,102 (0%) | 0% | 147.7 | 2,002,305 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 148.42 per share. | 01 Dec 2021 | 7,571 | 56,531 (0%) | 0% | 148.4 | 1,123,696 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 145.66 per share. | 01 Dec 2021 | 5,400 | 83,032 (0%) | 0% | 145.7 | 786,541 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 146.53 per share. | 01 Dec 2021 | 5,369 | 77,663 (0%) | 0% | 146.5 | 786,700 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 149.46 per share. | 01 Dec 2021 | 4,849 | 51,682 (0%) | 0% | 149.5 | 724,718 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 3,646 | 47,238 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Dec 2021 | 3,646 | 50,412 (0%) | 0% | 5.0 | 18,376 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 2,788 | 133,212 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.58 per share. | 01 Dec 2021 | 2,788 | 88,432 (0%) | 0% | 74.6 | 207,929 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 151.46 per share. | 01 Dec 2021 | 2,100 | 47,766 (0%) | 0% | 151.5 | 318,061 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 150.66 per share. | 01 Dec 2021 | 1,816 | 49,866 (0%) | 0% | 150.7 | 273,602 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 153.91 per share. | 01 Dec 2021 | 700 | 46,966 (0%) | 0% | 153.9 | 107,740 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 155.55 per share. | 01 Dec 2021 | 200 | 46,766 (0%) | 0% | 155.6 | 31,110 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 152.25 per share. | 01 Dec 2021 | 100 | 47,666 (0%) | 0% | 152.3 | 15,225 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 148.38 per share. | 22 Nov 2021 | 351 | 46,766 (0%) | 0% | 148.4 | 52,082 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 31,434 | 68,566 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 01 Nov 2021 | 31,434 | 88,783 (0%) | 0% | 11.5 | 360,862 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 163.87 per share. | 01 Nov 2021 | 24,125 | 50,229 (0%) | 0% | 163.9 | 3,953,296 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 163.15 per share. | 01 Nov 2021 | 11,829 | 74,354 (0%) | 0% | 163.2 | 1,929,950 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 10,232 | 50,884 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Nov 2021 | 10,232 | 57,349 (0%) | 0% | 5.0 | 51,569 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 164.75 per share. | 01 Nov 2021 | 3,112 | 47,117 (0%) | 0% | 164.8 | 512,706 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 162.06 per share. | 01 Nov 2021 | 1,500 | 86,183 (0%) | 0% | 162.1 | 243,091 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 160.50 per share. | 01 Nov 2021 | 1,100 | 87,683 (0%) | 0% | 160.5 | 176,554 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Oct 2021 | 41,666 | 88,783 (0%) | 0% | 5.0 | 209,997 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 41,666 | 61,116 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 143.97 per share. | 01 Oct 2021 | 21,469 | 49,617 (0%) | 0% | 144.0 | 3,090,892 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 143.13 per share. | 01 Oct 2021 | 13,297 | 71,086 (0%) | 0% | 143.1 | 1,903,154 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 142.16 per share. | 01 Oct 2021 | 4,400 | 84,383 (0%) | 0% | 142.2 | 625,491 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 144.77 per share. | 01 Oct 2021 | 2,500 | 47,117 (0%) | 0% | 144.8 | 361,923 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 161.85 per share. | 23 Aug 2021 | 337 | 47,117 (0%) | 0% | 161.8 | 54,543 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 02 Aug 2021 | 30,552 | 89,120 (0%) | 0% | 5.0 | 153,982 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 30,552 | 144,448 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 11,114 | 59,968 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 02 Aug 2021 | 11,114 | 58,568 (0%) | 0% | 1.2 | 13,337 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 180.13 per share. | 02 Aug 2021 | 10,713 | 64,454 (0%) | 0% | 180.1 | 1,929,777 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 181.13 per share. | 02 Aug 2021 | 8,800 | 55,654 (0%) | 0% | 181.1 | 1,593,961 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 179.08 per share. | 02 Aug 2021 | 8,050 | 75,167 (0%) | 0% | 179.1 | 1,441,596 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 178.25 per share. | 02 Aug 2021 | 5,903 | 83,217 (0%) | 0% | 178.2 | 1,052,191 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 181.98 per share. | 02 Aug 2021 | 5,200 | 50,454 (0%) | 0% | 182.0 | 946,300 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 183.02 per share. | 02 Aug 2021 | 1,800 | 48,654 (0%) | 0% | 183.0 | 329,441 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 184.02 per share. | 02 Aug 2021 | 800 | 47,854 (0%) | 0% | 184.0 | 147,220 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 184.95 per share. | 02 Aug 2021 | 400 | 47,454 (0%) | 0% | 185.0 | 73,981 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges